Peptide YYhormone Peptide YY (PYY) is a crucial gut hormone that plays a significant role in regulating appetite and has emerged as a potential therapeutic target for obesity. Research consistently indicates a strong association between PYY levels and body weight, with low circulating PYY concentrations often observed in individuals with obesity. Understanding the intricate relationship between PYY and obesity is vital for developing effective strategies to manage weight and improve metabolic health.
Peptide YY is primarily released from the L-cells in the intestinal lining in response to the presence of nutrients, particularly fats and carbohydrates, in the small intestinePeptide YY | Hormones. Once released into the bloodstream, PYY travels to the brain, where it acts on specific receptors in the hypothalamus to signal satiety and reduce feelings of hungerPeptide YY and Obesity: A Promising New Examination. This mechanism helps to curb food intake after a meal, contributing to overall energy balance.Peptide YY and Glucagon-like Peptide-1 Secretion in Obesity
Studies have shown that elevated PYY levels are associated with increased feelings of fullness and a subsequent decrease in appetite.Peptide YY and Glucagon-like Peptide-1 Secretion in Obesity Conversely, individuals with obesity often exhibit attenuated PYY release or reduced circulating PYY levels. This deficiency may lead to impaired satiety signals, potentially contributing to overeating and the development or maintenance of obesity.Peptide YY and glucagon-like peptide-1 contribute to ... The idea that PYY deficiency could be a cause of obesity has been explored, suggesting that PYY replacement therapy might be beneficialAdding PYY1875 to Semaglutide Yields Limited Weight ....
A substantial body of evidence links lower circulating PYY concentrations to higher body mass index (BMI) and obesity. Several studies have reported that obese individuals have lower baseline PYY levels compared to their lean counterparts2026年1月4日—The proposed mechanism involves delayed gastric emptying and increased release ofpeptide YY, though individual responses vary with baseline .... Furthermore, some research suggests that obese subjects may need to consume more calories to achieve the same increase in PYY levels seen in non-obese individuals, highlighting a potential dysregulation in PYY responsePeptide YY in Type 2 Diabetes: A Complementary Gut ....
Interestingly, factors like aerobic exercise have been shown to increase PYY levels, which in turn can reduce subsequent energy intake in both lean and obese adults. This finding underscores the potential of lifestyle interventions to positively influence PYY signaling.
Given its role in appetite regulation, PYY is considered a promising candidate for obesity treatment.作者：JA Cooper·2014·被引用次数：101—IncreasedPYYlevels as the result of aerobic exercise have also been shown to reduce subsequent energy intake in both lean andobese... Researchers are exploring various approaches to harness PYY's effects for weight management.
* PYY Analogs and Agonists: The development of synthetic PYY analogs and agonists aims to mimic or enhance the natural effects of PYY. These compounds are designed to activate PYY receptors more potently or for a longer duration, leading to sustained appetite suppression and weight loss. Some studies have investigated the combination of PYY analogs with other gut hormones like GLP-1 (glucagon-like peptide-1) to achieve greater efficacy in reducing body weight and improving metabolic parameters.作者：MH Tschöp·2007·被引用次数：8—Finally,PYY also uniquely represents the possible cause of obesityas well as its ultimate cure, since obese individuals have been found to be ... For instance, a combination therapy involving a PYY analog and semaglutide has shown promising results in clinical trials, leading to significant body weight loss.Peptide YY and Glucagon-like Peptide-1 in Morbidly Obese ... However, tolerability and gastrointestinal side effects can be a limiting factor in some casesEffect of Human Body Weight Changes on Circulating Levels ....
* Combined Therapies: The synergistic effects of PYY with other satiety hormones like GLP-1 and oxyntomodulin are also being investigated. Combined treatments have demonstrated improvements in body weight and glycemic control in individuals with obesity and prediabetes or type 2 diabetes作者：M Oertel·2024·被引用次数：12—A combinatory treatment with a non-selectivePYYanalog and semaglutide led to a maximum body weight loss of 14.0 ± 4.9% vs 9.9 ± 1.5% with semaglutide alone.. These multi-agonist approaches leverage the distinct but complementary actions of these hormones on appetite, energy expenditure, and glucose metabolism.
* Surgical Interventions: Bariatric surgery, such as Roux-en-Y gastric bypass, has been observed to lead to an exaggerated postprandial secretion of PYY and GLP-1. This enhanced release of gut hormones is thought to contribute to the significant appetite reduction and weight loss experienced by patients following such proceduresInhibition of Food Intake in Obese Subjects by Peptide YY3 ....
While PYY is a key player, it's important to understand its place alongside other gut hormones involved in appetite regulation.The role of peptide YY in appetite regulation and obesity - PMC GLP-1, for instance, is another crucial incretin hormone that also plays a role in satiety and glucose homeostasis. Unlike PYY, GLP-1 directly stimulates insulin release. Both PYY and GLP-1 are considered important therapeutic targets for obesity and type 2 diabetes, and their combined action is a focus of ongoing research. Understanding the distinct pathways and mechanisms of these hormones is critical for designing effective therapeutic strategies.
Despite the promising role of PYY in obesity management, challenges remainCombined GLP-1, Oxyntomodulin, and Peptide YY Improves .... The precise mechanisms by which PYY levels are dysregulated in obesity are still being fully elucidated. Furthermore, optimizing the delivery and efficacy of PYY-based therapies while minimizing side effects is an ongoing area of research.Peptide YY(PYY) is a peptide hormone present in the brain and is released from the bowel in response to fat and carbohydrate in the small intestine. Future investigations will likely focus on developing more potent and well-tolerated PYY analogs, exploring novel combination therapies, and understanding the long-term effects of PYY modulation on weight management and overall metabolic health.作者：MH Tschöp·2007·被引用次数：8—Finally,PYY also uniquely represents the possible cause of obesityas well as its ultimate cure, since obese individuals have been found to be ...
In conclusion, Peptide YY is a critical hormone in the complex interplay of appetite regulation and energy balance. Its association with obesity, particularly the observation of lower PYY levels in affected individuals, positions it as a significant target for therapeutic interventionPeptide YY(PYY) is a peptide hormone present in the brain and is released from the bowel in response to fat and carbohydrate in the small intestine.. Continued research into PYY and its interactions with other hormones holds substantial promise for developing effective strategies to combat the growing global challenge of obesity.
Join the newsletter to receive news, updates, new products and freebies in your inbox.